1-9 of 9
thiostrepton
Close
Sort by
Journal Articles

FOXM1 and the NPM-ALK/STAT3 Axis Form a Novel Positive Feedback Loop in Promoting the Oncogenesis of ALK-Positive Anaplastic Large Cell Lymphoma

Peng Wang, MD PhD, Moinul Haque, Jing Li, Yung-Hsing Huang, Meaad Almowaled, Carter Bargar, Adam Karpf, Will Chen, Suzanne Turner, Raymond Lai, PhD MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3921.
https://doi.org/10.1182/blood-2018-99-115743
Published: 2018
Journal Articles

FoxM1-Mediated Signaling Promotes the Progression of Mantle Cell Lymphoma

Hui Guo, PhD, Yixin Yao, PhD, Hui Zhang, Elizabeth Lorence, Makhdum Ahmed, MD PhD MPH, Lingyan Ping, MD PhD, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4176.
https://doi.org/10.1182/blood-2018-99-119349
Published: 2018
Journal Articles

FoxM1: A New Therapeutic Target for Mantle Cell Lymphoma

Hui Guo, MD PhD, Hui Zhang, Makhdum Ahmed, MD MPH, PhD, Yang Liu, MD, Shengjian Huang, PhD, Victoria Zhang, Jeffrey Wang, Elyse Lopez, Elizabeth A Lorence, MPH, Jacqueline Wang, Swathi Balaji, Merolle Maria, Changying Jiang, PhD, Krystle Nomie, PhD, Michael Wang, BS, Liang Zhang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1469.
https://doi.org/10.1182/blood.V130.Suppl_1.1469.1469
Published: 2017
Journal Articles

Loss of FoxM1 Promotes Erythroid Differentiation through Increased Proliferation of Erythroid Progenitors

Minyoung Youn, PhD, Elena Bibikova, PhD, Corinne LaVasseur, BA, Bertil Glader, MD PhD, Kathleen Sakamoto, MD PhD, Anupama Narla, MD
Journal: Blood
Blood (2015) 126 (23): 933.
https://doi.org/10.1182/blood.V126.23.933.933
Published: 2015
Journal Articles

FOXM1 Is Overexpressed in B-Acute Lymphoblastic Leukemia (B-All) and Its Inhibition Sensitizes B-All Cells to Chemotherapeutic Drugs

Francesca Consolaro, MS, Giuseppe Basso, MD, Giampietro Viola, PhD, Eric W-.F. Lam, PhD
Journal: Blood
Blood (2014) 124 (21): 2245.
https://doi.org/10.1182/blood.V124.21.2245.2245
Published: 2014
Journal Articles

FOXM1 Mediates Drug-Resistance and Represents a Therapeutic Target in Pre-B Acute Lymphoblastic Leukemia

Maike Buchner, PhD, Eugene Park, Lars Klemm, Huimin Geng, PhD, Dragana Kopanja, Pradip Raychaudhuri, PhD, Markus Muschen, MDPhD
Journal: Blood
Blood (2014) 124 (21): 790.
https://doi.org/10.1182/blood.V124.21.790.790
Published: 2014
Journal Articles

Identification Of FOXM1 As Therapeutic Target In BCR-ABL1 Positive Acute Lymphoblastic Leukemia

Maike Buchner, PhD, Eugene Park, Lars Klemm, MSc, Huimin Geng, PhD, Dragana Kopanja, Pradip Raychaudhuri, PhD, Markus Muschen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1250.
https://doi.org/10.1182/blood.V122.21.1250.1250
Published: 2013
Journal Articles

Identification of FoxM1 As Therapeutic Target in TKI-Resistant Ph + ALL

Maike Buchner, PhD, Lars Klemm, MSc, Chen Zhengshan, MD, PhD, Huimin Geng, PhD, Markus Muschen, MD
Journal: Blood
Blood (2012) 120 (21): 874.
https://doi.org/10.1182/blood.V120.21.874.874
Published: 2012
Journal Articles

Discovery and Characterization of Macrocyclic Thiopeptide Proteasome Inhibitors for Hematologic Malignancies

Sridevi Ponduru, M.D., Raymond Moellering, Edward Greenberg, John Paul Ying-Ching Shen, M.D., Benjamin Z Stanton, James E. Bradner, M.D
Journal: Blood
Blood (2008) 112 (11): 3669.
https://doi.org/10.1182/blood.V112.11.3669.3669
Published: 2008